SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-070377
Filing Date
2023-06-12
Accepted
2023-06-12 16:31:36
Documents
7
Effectiveness Date
2023-06-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2318276d1_s8.htm S-8 40382
2 EXHIBIT 5.1 tm2318276d1_ex5-1.htm EX-5.1 6896
3 EXHIBIT 23.1 tm2318276d1_ex23-1.htm EX-23.1 2280
4 EXHIBIT 23.2 tm2318276d1_ex23-2.htm EX-23.2 2314
5 EXHIBIT 23.3 tm2318276d1_ex23-3.htm EX-23.3 2142
6 EXHIBIT 99.1 tm2318276d1_ex99-1.htm EX-99.1 151062
7 EX-FILING FEES tm2318276d1_ex-filingfees.htm EX-FILING FEES 10120
  Complete submission text file 0001104659-23-070377.txt   216536
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272602 | Film No.: 231008570
SIC: 2836 Biological Products, (No Diagnostic Substances)